NCT03837496View on ClinicalTrials.gov

Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

August 17, 2021

Study Completion Date

December 1, 2021

Conditions

Breast CancerAdherence, Medication

Interventions

OTHER

STRIDE

STRIDE is a brief, group-based, virtual (videoconference) cognitive-behavioral intervention. The intervention incorporates adherence problem-solving, cognitive restructuring, relaxation training, symptom management, coping skills training, and mindfulness techniques.

OTHER

Medication Monitoring Control

Care provided as standard by the hospital and medication monitoring

Trial Locations (1)

02114

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03837496 - Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors | Biotech Hunter | Biotech Hunter